Laatiri M A, Chehata S, Amouri A, Sendi H S, Saad A, Ennabli S
Service d'Hématologie Clinique, CHU Farhat Hached de Sousse-Tunisie.
Tunis Med. 2001 Jan;79(1):38-41.
Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) is an aggressive form of acute leukemia that children ALL. Between 1991 and 1998, eight cases Ph+ ALL (7 males and one female) were diagnosed in our institution by successful cytogenetic studies. Median age was 37 years (range, 1-60 years). Leukocyte count was more than 50 x 109/l in 5 cases. According to the French-American-British (FAB) criteria, six patients were classified L1 and two L2. The Ph+ as sole anomaly was seen in 2 patients (25%), while additional chromosome changes were observed in 6 cases. Complete remission was achieved in 5 cases (62%) and relapse was observed in all cases? The 2-year survival rae was 25% confirming the worse prognosis of this leukemia when treated with standard chemotherapy.
费城染色体阳性(Ph+)急性淋巴细胞白血病(ALL)是一种侵袭性急性白血病,在儿童ALL中存在。1991年至1998年期间,通过成功的细胞遗传学研究,我院诊断出8例Ph+ ALL(7例男性和1例女性)。中位年龄为37岁(范围1至60岁)。5例患者白细胞计数超过50×10⁹/L。根据法国-美国-英国(FAB)标准,6例患者分类为L1,2例为L2。2例患者(25%)Ph+为唯一异常,而6例观察到额外的染色体改变。5例(62%)实现完全缓解,所有病例均观察到复发?2年生存率为25%,证实了这种白血病采用标准化疗时预后较差。